首页 > 最新文献

Media Penelitian dan Pengembangan Kesehatan最新文献

英文 中文
Front Matter Media Litbangkes Vol 31 No. 3 《前事传媒》第31卷第3期
IF 0.1 Pub Date : 2022-01-12 DOI: 10.22435/mpk.v31i3.5799
Sri Lestari
{"title":"Front Matter Media Litbangkes Vol 31 No. 3","authors":"Sri Lestari","doi":"10.22435/mpk.v31i3.5799","DOIUrl":"https://doi.org/10.22435/mpk.v31i3.5799","url":null,"abstract":"","PeriodicalId":18323,"journal":{"name":"Media Penelitian dan Pengembangan Kesehatan","volume":"61 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78752240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Full Pages Media Litbangkes Vol 31 No 3 全页媒体Litbangkes卷31第3号
IF 0.1 Pub Date : 2022-01-12 DOI: 10.22435/mpk.v31i3.5801
Sri Lestari
{"title":"Full Pages Media Litbangkes Vol 31 No 3","authors":"Sri Lestari","doi":"10.22435/mpk.v31i3.5801","DOIUrl":"https://doi.org/10.22435/mpk.v31i3.5801","url":null,"abstract":"","PeriodicalId":18323,"journal":{"name":"Media Penelitian dan Pengembangan Kesehatan","volume":"14 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76444528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Back Matter Media Litbangkes Vol 31 No 3 Back Matter Media Litbangkes第31卷第3期
IF 0.1 Pub Date : 2022-01-12 DOI: 10.22435/mpk.v31i3.5800
Sri Lestari
{"title":"Back Matter Media Litbangkes Vol 31 No 3","authors":"Sri Lestari","doi":"10.22435/mpk.v31i3.5800","DOIUrl":"https://doi.org/10.22435/mpk.v31i3.5800","url":null,"abstract":"","PeriodicalId":18323,"journal":{"name":"Media Penelitian dan Pengembangan Kesehatan","volume":"106 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76237602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Full Pages Media Litbangkes Vol 31 No 2 全页媒体Litbangkes卷31第2号
IF 0.1 Pub Date : 2022-01-12 DOI: 10.22435/mpk.v31i2.5805
Atmarita Editor
{"title":"Full Pages Media Litbangkes Vol 31 No 2","authors":"Atmarita Editor","doi":"10.22435/mpk.v31i2.5805","DOIUrl":"https://doi.org/10.22435/mpk.v31i2.5805","url":null,"abstract":"","PeriodicalId":18323,"journal":{"name":"Media Penelitian dan Pengembangan Kesehatan","volume":"58 10 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79213774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinan Penggunaan Rokok Elektronik pada Remaja di Jakarta Pusat Tahun 2020
IF 0.1 Pub Date : 2021-12-31 DOI: 10.22435/mpk.v31i4.4872
M. Wahidin, Rini Handayani, Ira Marti Ayu
The use of electronic cigarette becomes a health problem among teenagers. The prevalence of this cigarette smokers in Jakarta is higher than national prevalence. The aim of this study was to identify determinants of usage of electronic cigarette among teenagers in the City of Central Jakarta. This was an observational study using cross sectional study design. The research was conducted in April – October 2020 in Central Jakarta, Jakarta province. The sample of schools was taken by purposive sampling using criteria of representativeness to public and private schools for general and vocational school, with total of 240 respondents from 4 selected schools. Primary data was collected through online questionnaire (google form). Bivariate analysis was performed to identify relationship between independent variables with dependent variable using Chi Square test and multivariate analyses was conducted using Multiple Logistic Regression. Result of the study showed that proportion of electronic cigarette usage was 8.3%, majority temporary users (95%), The users start to use electronic cigarette in age of 14 years (33.3%) with youngest at 8 years. The reasons of using electronic cigarette were influence of friends (44.8%), lifestyle/satisfactory (20.7%), and no nicotine (17.2%). There was significant association of knowledge, attitude, affordability of electronic cigarette prize, influence of friends, and influence of artist/public figure with using electronic cigarette. The most influent determinants of electronic cigarette usage among adolescents were knowledge and affordability of electronic cigarette prize. Abstrak Penggunaan rokok elektronik saat ini menjadi permasalahan kesehatan pada remaja. Prevalensi pengguna rokok elektronik di DKI Jakarta lebih tinggi dari prevalensi nasional. Tujuan penelitian ini adalah untuk mengetahui determinan penggunaan rokok elektronik pada remaja (siswa SMA/sederajat) di Jakarta Pusat. Penelitian ini merupakan penelitian observasional dengan desain cross sectional. Penelitian dilaksanakan pada April – Oktober 2020 di Kota Jakarta Pusat, Provinsi DKI Jakarta. Pengambilan sampel sekolah SMA/sederajat dilakukan secara purposive sampling, berdasarkan kriteria mewakili sekolah negeri dan swasta, SMA Umum, dan SMK, dengan besar sampel 240 responden dari 4 sekolah terpilih. Pengumpulan data primer menggunakan kuesioner secara online (google form). Analisis bivariat untuk mengetahui hubungan variabel independen dengan penggunaan rokok elektronik menggunakan uji Chi Square dan analisis multivariat menggunakan Uji Logistik Regresi Ganda. Hasil penelitian menunjukkan bahwa proporsi penggunaan rokok elektronik pada remaja SMA sebesar 8,3%, dengan mayoritas (95%) kadang-kadang dalam menggunakan rokok elektronik. Pengguna sebagian besar mulai menggunakan rokok elektronik pada usia 14 tahun (33,3%), dan paling muda pada usia 8 tahun. Alasan menggunakan rokok elektronik sebagian besar adalah pengaruh teman (44,8%), gaya hidup/kepuasan
电子烟的使用已成为青少年的健康问题。这类吸烟者在雅加达的流行率高于全国流行率。本研究的目的是确定雅加达市中心青少年使用电子烟的决定因素。这是一项采用横断面研究设计的观察性研究。该研究于2020年4月至10月在雅加达省雅加达中部进行。学校样本采用有目的抽样,采用公立和私立学校的代表性标准为普通和职业学校,共有240名受访者来自4所选定的学校。主要数据通过在线问卷(google表格)收集。双变量分析采用卡方检验确定自变量与因变量之间的关系,多变量分析采用多元逻辑回归。研究结果显示,电子烟的使用比例为8.3%,大多数是临时使用者(95%),用户开始使用电子烟的年龄为14岁(33.3%),最年轻的是8岁。使用电子烟的原因依次为朋友影响(44.8%)、生活方式/满意程度(20.7%)、无尼古丁(17.2%)。使用电子烟的知识、态度、电子烟奖品的可负担性、朋友的影响、艺人/公众人物的影响与使用电子烟有显著相关。青少年使用电子烟最具影响力的决定因素是电子烟的知识和可负担性。[摘要]彭家南rokok电子产品的生产与销售,是彭家南永续发展的基础。印度尼西亚雅加达,印度尼西亚,印度尼西亚,印度尼西亚,印度尼西亚。图juan penelitian ini adalah untuk mengetahui determinan penggunaan rokok electronics pada remaja (siswa SMA/sederajat) di Jakarta pusa。Penelitian ini merupakan Penelitian观测登根设计截面。Penelitian dilaksanakan pada 2020年4月至10月di Kota Jakarta Pusat,省DKI雅加达。penghambilan样本sekolah /sederajat dilakukan secara目的抽样,berdasarkan标准mewakili sekolah negeri dan swasta, SMA Umum, dan SMK, dentan besar样本240个应答者达4个sekolah terpilih。彭普兰数据入门,孟古纳坎kuesioner secara在线(谷歌表格)。单变量分析,单变量分析,单变量分析,单变量分析,单变量分析,单变量分析,单变量分析,单变量分析,单变量分析。Hasil penelitian menunjukkan bahwa proporsi penggunaan rokok elekonik pada remaja SMA sebesar 8,3%, dengan mayoritas (95%) kadang-kadang dalam menggunakan rokok elekonik。彭古那市的巴吉安市的穆雷市的孟古那肯市的罗科克市的电子工业的帕达乌斯市14个塔洪(33.3%),丹帕达乌斯市8个塔洪。Alasan menggunakan rokok elektronik sebagian besar adalah pengaruh teman (44.8%), gaya hidup/kepuasan (20.7%), dan tidak mengandung nikotin(17.2%)。Ada hubungan yang signfikan antara pengetahuan, sikap, keterjangkaan harga rokok electronics, pengaruh teman, dan pengaruh艺术家/公众人物dengan penggunaan rokok electronics。确定杨培平berhubungan terhahappenggunaan rokok electronics . pada remaja adalah pengetahuan dan kerterjangkaan harga rokok electronics。
{"title":"Determinan Penggunaan Rokok Elektronik pada Remaja di Jakarta Pusat Tahun 2020","authors":"M. Wahidin, Rini Handayani, Ira Marti Ayu","doi":"10.22435/mpk.v31i4.4872","DOIUrl":"https://doi.org/10.22435/mpk.v31i4.4872","url":null,"abstract":"The use of electronic cigarette becomes a health problem among teenagers. The prevalence of this cigarette smokers in Jakarta is higher than national prevalence. The aim of this study was to identify determinants of usage of electronic cigarette among teenagers in the City of Central Jakarta. This was an observational study using cross sectional study design. The research was conducted in April – October 2020 in Central Jakarta, Jakarta province. The sample of schools was taken by purposive sampling using criteria of representativeness to public and private schools for general and vocational school, with total of 240 respondents from 4 selected schools. Primary data was collected through online questionnaire (google form). Bivariate analysis was performed to identify relationship between independent variables with dependent variable using Chi Square test and multivariate analyses was conducted using Multiple Logistic Regression. Result of the study showed that proportion of electronic cigarette usage was 8.3%, majority temporary users (95%), The users start to use electronic cigarette in age of 14 years (33.3%) with youngest at 8 years. The reasons of using electronic cigarette were influence of friends (44.8%), lifestyle/satisfactory (20.7%), and no nicotine (17.2%). There was significant association of knowledge, attitude, affordability of electronic cigarette prize, influence of friends, and influence of artist/public figure with using electronic cigarette. The most influent determinants of electronic cigarette usage among adolescents were knowledge and affordability of electronic cigarette prize. \u0000Abstrak \u0000Penggunaan rokok elektronik saat ini menjadi permasalahan kesehatan pada remaja. Prevalensi pengguna rokok elektronik di DKI Jakarta lebih tinggi dari prevalensi nasional. Tujuan penelitian ini adalah untuk mengetahui determinan penggunaan rokok elektronik pada remaja (siswa SMA/sederajat) di Jakarta Pusat. Penelitian ini merupakan penelitian observasional dengan desain cross sectional. Penelitian dilaksanakan pada April – Oktober 2020 di Kota Jakarta Pusat, Provinsi DKI Jakarta. Pengambilan sampel sekolah SMA/sederajat dilakukan secara purposive sampling, berdasarkan kriteria mewakili sekolah negeri dan swasta, SMA Umum, dan SMK, dengan besar sampel 240 responden dari 4 sekolah terpilih. Pengumpulan data primer menggunakan kuesioner secara online (google form). Analisis bivariat untuk mengetahui hubungan variabel independen dengan penggunaan rokok elektronik menggunakan uji Chi Square dan analisis multivariat menggunakan Uji Logistik Regresi Ganda. Hasil penelitian menunjukkan bahwa proporsi penggunaan rokok elektronik pada remaja SMA sebesar 8,3%, dengan mayoritas (95%) kadang-kadang dalam menggunakan rokok elektronik. Pengguna sebagian besar mulai menggunakan rokok elektronik pada usia 14 tahun (33,3%), dan paling muda pada usia 8 tahun. Alasan menggunakan rokok elektronik sebagian besar adalah pengaruh teman (44,8%), gaya hidup/kepuasan","PeriodicalId":18323,"journal":{"name":"Media Penelitian dan Pengembangan Kesehatan","volume":"14 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78423790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uji Toksisitas Akut Ekstrak Etanol Daun Kayu Jawa (Lannea coromandelica (Houtt.) Merr.) pada Tikus Wistar
IF 0.1 Pub Date : 2021-12-31 DOI: 10.22435/mpk.v31i4.4660
Nona Rahmaida Puetri, Marlinda Marlinda, Bayakmiko Yunsa, Sukmayati Alegantina, Dian Sundari
Lannea coromandelica (Houtt.) Merr leaves are one of the herbal medicine that are often used by Indonesian people. Empirically, this plant can be used for an alternative therapy which the latex can be used for wounds, the leaves can be used for the swollen due to the sprain, also be used for eyestrain, toothache, venomous bites treatments and the cortext has some efficacy as anti-inflammatory, antimitotic, and antioxidant. However, the safety of using leaves as herbal medicine has not been studied before. The previous research showed that the trunk and the leaves of Lannea coromandelica (Houtt.) Merr. contained saponin, flavonoid, and tannin. The ethanol extract of Lannea coromandelica (Houtt.) Merr. skin also contained antibacterial and antioxidant. The phytochemicals test showed that the ethanol extract of Lannea coromandelica (Houtt.) Merr. leaves contained flavonoid, steroid, terpenoid, saponin, tannin, and phenolic. The aim of this study was to determine the lethal dose of giving Lannea coromandelica (Houtt.) Merr. leaves ethanol extract, so that it could give the security of its use. This study used experimental laboratory, using 15 female rats, with treatment are P1(500mg/kgBW), P2 (3000mg/kgBW) and P3 (5500mg/KgBW). The data were collected by observing clinical symptoms for 24 hours, the number of deaths, then for 2 weeks observed the effects of toxicity delay and then the rats was dissected to observe the organ microscopically/histologically. The LD50 value of leaf extract of the L. coromandelica. was greater than 5000 mg/kg BW which mean the extract is non-toxic practical category. Abstrak Daun Kayu Jawa (Lannea coromandelica (Houtt.) Merr.) merupakan salah satu obat herbal yang sering digunakan oleh masyarakat Indonesia. Secara empiris tanaman ini biasa digunakan untuk pengobatan seperti getahnya sebagai obat luka, daunnya untuk mengobati pembengkakan akibat keseleo, sakit mata, sakit gigi, gigitan binantang berbisa dan korteks kayu jawa mempunyai khasiat sebagai antiinflamasi, antimitosis, dan antioksidan. Namun, penggunaan daun sebagai obat herbal keamanannya belum pernah diuji. Penelitian sebelumnya menunjukkan bahwa batang dan daun Kayu Jawa mengandung saponin, flavonoida, dan tanin. Ekstrak etanol kulit Kayu Jawa juga mengandung antibakteri dan antioksidan. Uji fitokimia menunjukkan ekstrak etanol daun Kayu Jawa mengandung flavonoid, steroid, terpenoid, saponin, tanin, dan fenolik. Tujuan penelitian adalah untuk mengetahui nilai toksisitas (LD50) ekstrak etanol 70% daun Kayu Jawa, sehingga dapat memberikan keamanan dalam penggunannya. Penelitian dilakukan menggunakan 15 ekor tikus galur Wistar betina. Dosis ekstrak yang dicoba adalah P1(500 mg/kgBB), P2 (3000mg/kgBB), dan P3 (5500mg/KgBB) yang diberikan secara oral. Gejala klinis toksisitas diamati selama 24 jam setelah pemberian bahan coba untuk melihat jumlah kematian. Pengamatan dilanjutkan selama dua minggu untuk mengetahui efek farmakodinamik. Selain itu juga dilakukan peng
(胡特语)山楂叶是印尼人常用的草药之一。根据经验,这种植物可用于替代疗法,乳胶可用于伤口,叶子可用于扭伤引起的肿胀,也可用于眼疲劳,牙痛,毒蛇咬伤的治疗,其背景具有抗炎,抗分裂和抗氧化的功效。然而,使用叶子作为中草药的安全性还没有研究。以往的研究表明,长叶Lannea coromandelica (Houtt.)稳定。含皂苷、类黄酮、单宁。木榄醇提物的研究稳定。皮肤还含有抗菌和抗氧化剂。植物化学成分试验表明,木榄醇提物具有明显的抗氧化活性。稳定。叶片含有黄酮类、甾类、萜类、皂苷、单宁和酚类。本研究的目的是确定给药兰草的致死剂量(Houtt。稳定。叶片乙醇提取物,使其在使用中具有安全性。本研究采用实验室方法,雌性大鼠15只,分别给予P1(500mg/kgBW)、P2 (3000mg/kgBW)和P3 (5500mg/ kgBW)处理。采用24小时临床症状观察、死亡数观察、2周毒性延迟效应观察、解剖器官显微/组织学观察等方法收集数据。芫荽叶提取物的LD50值。均大于5000mg /kg BW,为无毒实用类提取物。【摘要】胡特岛龙葵(Lannea coromandelica)mermr .) merupakan salah satu obat herbal yang sering digunakan oleh masyarakat印度尼西亚。Secara empiris tanaman ini biasa digunakan untuk pengobatan seperti getahnya sebagai obat luka, daunnya untuk mengobati pembengkakan akibat keseleo, sakit mata, sakit gigi, gigitan binantang berbisa dan korteks kayu jawa mempunyai khasiat sebagai抗炎,抗有丝分裂,抗氧化。Namun, penggunaan和sebagai obat草本植物keamanannya belum pernah diuji。黄酮类化合物,单宁。Ekstrak etanol kulit Kayu java juga mengandung抗细菌和抗oksidan。黄酮类、甾体、萜类、皂苷、单宁、丹芬利克。Tujuan penelitian adalah untuk mengetahui nilai toksisitas (LD50) ekstrak乙醇70% dau Jawa, sehinga dapikan keamanan dalam penggunannya。Penelitian dilakukan menggunakan 15 ekor tikus galur Wistar betina。剂量分别为:阳降毒药P1(500mg/ kgBB)、P2 (3000mg/kgBB)、P3 (5500mg/ kgBB)。Gejala klinis toksisitas diamati selama 24 jam setelah pemberian bahan untuk melihat jumlah kematian。彭马丹dilanjutkan selama dua minggu untuk mengetahui efek farmakodinamik。Selain itu juga dilakukan pengamatan个体terhadap ada tidaknya gejala keracunan dengan cara tikus dikorbankan untuk ambil dan diamati组织病理学ya secara显微病理学/组织学paada器官hati, paru, ginal, jantung, usus, lambung, danlimpa。达哈西尔penelitian menunjukkan nilai LD50 ekstrak daan Kayu爪哇(L. coromandelica) lebih besar Dari 5000 mg/kg BB masuk kedalam kategori praktis tidak beracun(几乎无毒)。
{"title":"Uji Toksisitas Akut Ekstrak Etanol Daun Kayu Jawa (Lannea coromandelica (Houtt.) Merr.) pada Tikus Wistar","authors":"Nona Rahmaida Puetri, Marlinda Marlinda, Bayakmiko Yunsa, Sukmayati Alegantina, Dian Sundari","doi":"10.22435/mpk.v31i4.4660","DOIUrl":"https://doi.org/10.22435/mpk.v31i4.4660","url":null,"abstract":"Lannea coromandelica (Houtt.) Merr leaves are one of the herbal medicine that are often used by Indonesian people. Empirically, this plant can be used for an alternative therapy which the latex can be used for wounds, the leaves can be used for the swollen due to the sprain, also be used for eyestrain, toothache, venomous bites treatments and the cortext has some efficacy as anti-inflammatory, antimitotic, and antioxidant. However, the safety of using leaves as herbal medicine has not been studied before. The previous research showed that the trunk and the leaves of Lannea coromandelica (Houtt.) Merr. contained saponin, flavonoid, and tannin. The ethanol extract of Lannea coromandelica (Houtt.) Merr. skin also contained antibacterial and antioxidant. The phytochemicals test showed that the ethanol extract of Lannea coromandelica (Houtt.) Merr. leaves contained flavonoid, steroid, terpenoid, saponin, tannin, and phenolic. The aim of this study was to determine the lethal dose of giving Lannea coromandelica (Houtt.) Merr. leaves ethanol extract, so that it could give the security of its use. This study used experimental laboratory, using 15 female rats, with treatment are P1(500mg/kgBW), P2 (3000mg/kgBW) and P3 (5500mg/KgBW). The data were collected by observing clinical symptoms for 24 hours, the number of deaths, then for 2 weeks observed the effects of toxicity delay and then the rats was dissected to observe the organ microscopically/histologically. The LD50 value of leaf extract of the L. coromandelica. was greater than 5000 mg/kg BW which mean the extract is non-toxic practical category. \u0000Abstrak \u0000Daun Kayu Jawa (Lannea coromandelica (Houtt.) Merr.) merupakan salah satu obat herbal yang sering digunakan oleh masyarakat Indonesia. Secara empiris tanaman ini biasa digunakan untuk pengobatan seperti getahnya sebagai obat luka, daunnya untuk mengobati pembengkakan akibat keseleo, sakit mata, sakit gigi, gigitan binantang berbisa dan korteks kayu jawa mempunyai khasiat sebagai antiinflamasi, antimitosis, dan antioksidan. Namun, penggunaan daun sebagai obat herbal keamanannya belum pernah diuji. Penelitian sebelumnya menunjukkan bahwa batang dan daun Kayu Jawa mengandung saponin, flavonoida, dan tanin. Ekstrak etanol kulit Kayu Jawa juga mengandung antibakteri dan antioksidan. Uji fitokimia menunjukkan ekstrak etanol daun Kayu Jawa mengandung flavonoid, steroid, terpenoid, saponin, tanin, dan fenolik. Tujuan penelitian adalah untuk mengetahui nilai toksisitas (LD50) ekstrak etanol 70% daun Kayu Jawa, sehingga dapat memberikan keamanan dalam penggunannya. Penelitian dilakukan menggunakan 15 ekor tikus galur Wistar betina. Dosis ekstrak yang dicoba adalah P1(500 mg/kgBB), P2 (3000mg/kgBB), dan P3 (5500mg/KgBB) yang diberikan secara oral. Gejala klinis toksisitas diamati selama 24 jam setelah pemberian bahan coba untuk melihat jumlah kematian. Pengamatan dilanjutkan selama dua minggu untuk mengetahui efek farmakodinamik. Selain itu juga dilakukan peng","PeriodicalId":18323,"journal":{"name":"Media Penelitian dan Pengembangan Kesehatan","volume":"16 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84404866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Kajian: Aplikasi Sel Punca Mesenkim pada Tata Laksana Klinis Penyakit Stroke
IF 0.1 Pub Date : 2021-12-31 DOI: 10.22435/mpk.v31i4.4465
Ariyani Noviantari, Tati Febrianti
Stroke is a neurodegenerative disease that can cause disability to death. Stroke therapy useing stem cells is starting to be considered as an alternative in terms of availability, propagation potential, and differentiation ability. Stem cells are cells that have the ability to reproduce (self-renewal), do not yet have a specific shape and functions (undifferentiated), but have the ability todifferentiate into other cells. One type of stem cell is mesenchymal stem cell (MSC) which can differentiate in vitro into other cells including neurons. In addition MSC can secrete various neurotrophic factors that can play a role in angiogenesis and synaptic formation, so that, it is relevant to stroke therapy. This paper describes the research and development of stem cell applications in stroke therapy through several research results. This paper is in the form of a literature review obtained through literature searches. The results showed that MSC is able to differentiate and replace damaged neurons after transplantation based on the results of studies in vitro, in vivo, and several clinical trials. The technique in the differentiation of MSCinto neurons is the addition of certain growth factors to the culture medium in vitro. Meanwhile, in vivo studies have shown that that administration of MSC can replace damaged cells, provide neuroprotective effect, induce axon growth, stimulate angiogenesis, and neurogenesis in stroke animal models using the middle cerebral artery occlusion (MCAO) method. Therefore, MSCs have the potential to treat degenerative diseases, especially stroke. From the results of clinical trials, it can be seen that stem cells are safe to give to stroke patients, there is clinical improvement, and neurological improvement, as well as a reduction in brain lesions. However, there are several challenges for the development and application of MSS for stroke therapy in the future such as concerns about tumorigenesis and high cost.  Abstrak Stroke adalah penyakit neurodegeneratif yang dapat menyebabkan kecacatan hingga kematian. Terapi stroke menggunakan sel punca mulai dipikirkan sebagai alternatif dilihat dari aspek ketersediaan, potensi perbanyakan, dan kemampuan diferensiasinya. Sel punca merupakan sel yang memiliki kemampuan memperbanyak diri (self renewal), belum mempunyai bentuk dan fungsi yang spesifik (undifferentiated), namun memiliki kemampuan untuk berdiferensiasi menjadi sel lainnya. Salah satu jenis sel punca adalah sel punca mesenkim (SPM) yang dapat berdiferensiasi secara in vitro menjadi sel lain termasuk neuron. Selain itu, SPM dapat menyekresikan berbagai faktor neurotrofik yang dapat berperan dalam angiogenesis dan pembentukan sinaptik sehingga relevan terhadap terapi terhadap stroke. Tulisan ini menguraikan tentang penelitian dan pengembangan sel punca dalam terapi stroke melalui beberapa hasil penelitian. Tulisan ini berupa review literatur yang didapatkan melalui penelusuran pustaka. Hasilnya menunjukkan bahwa SPM mampu
中风是一种神经退行性疾病,可导致残疾甚至死亡。从可用性、繁殖潜力和分化能力的角度来看,使用干细胞治疗中风开始被认为是一种替代方法。干细胞是具有繁殖能力(自我更新)的细胞,尚未具有特定的形状和功能(未分化),但具有分化成其他细胞的能力。一种干细胞是间充质干细胞(MSC),它可以在体外分化成包括神经元在内的其他细胞。此外,间充质干细胞还能分泌多种神经营养因子,参与血管生成和突触形成,因此与脑卒中治疗有关。本文通过几项研究成果介绍了干细胞在脑卒中治疗中的应用研究进展。本文采用文献综述的形式,通过文献检索获得。基于体外、体内及多项临床试验的研究结果表明,MSC在移植后能够分化和替代受损神经元。骨髓间充质干细胞向神经元分化的技术是在体外培养基中加入一定的生长因子。同时,体内研究表明,采用大脑中动脉闭塞(MCAO)方法的脑卒中动物模型中,给药间充质干细胞可以替代受损细胞,提供神经保护作用,诱导轴突生长,刺激血管生成和神经发生。因此,间充质干细胞具有治疗退行性疾病,特别是中风的潜力。从临床试验的结果可以看出,干细胞用于中风患者是安全的,有临床改善,神经系统改善,以及脑部病变的减少。然而,未来MSS在脑卒中治疗中的发展和应用还面临着一些挑战,如肿瘤发生和成本高。【摘要】脑卒中可引起神经退行性阳痿,可引起脑卒中、脑卒中、脑卒中和脑卒中。Terapi stroke menggunakan sel punca mulai dipikirkan sebagai alternate dililihat dari speak ketersediaan, potential perbanyakan, dan kemampuan difference asinya。Sel punca merupakan Sel yang memiliki kemampuan memperbanyak diri(自我更新),belum mempunyai bentuk dan fungsi yang spesfik(未分化),namun memiliki kemampuan untuk berdifersiasi menjadi Sel lainnya。Salah satu jenis sel punca adalah sel punca mesenkim (SPM) yang dapat berberdisisias secara离体menjadi sel termasuk神经元。Selain itu, SPM, dapat menyekresikan, berbagai, neurotrofik, dapat berperan血管生成,pembentukan, sinaptik, sega,相关性,terhadap, terhadap卒中。图里桑尼蒙古莱坎tentang penelitian danpengembangan selpunca dalam terapi卒中melalui beberapa hasil penelitian。土立三省、省、省、省、省、省文献综述。猕猴神经元的体外移植,猕猴神经元的体内移植,猕猴神经元的体外移植,猕猴神经元的体外移植。在离体培养基培养中,细胞因子-因子对细胞因子的影响。脑卒中登干脑中动脉闭塞(MCAO)模型脑卒中登干脑中动脉闭塞(MCAO)的研究退行性畸形瘤脑卒中的研究。Dari hasil uji klinis terlihat bahwa sel punca aman diberikan kepada pasen卒中,terjadi perbaikan klinis, dan perbaikan神经学,serta terjadi pengurangan lesi di tak。Namun, terdapat beberapa tantangan untuk pengembangan dan applikasi SPM untuk terapi卒中dimasa mendatang, serperti kekhawatiran terjadinya肿瘤发生dan biaya yang cucuup mahal。
{"title":"Kajian: Aplikasi Sel Punca Mesenkim pada Tata Laksana Klinis Penyakit Stroke","authors":"Ariyani Noviantari, Tati Febrianti","doi":"10.22435/mpk.v31i4.4465","DOIUrl":"https://doi.org/10.22435/mpk.v31i4.4465","url":null,"abstract":"Stroke is a neurodegenerative disease that can cause disability to death. Stroke therapy useing stem cells is starting to be considered as an alternative in terms of availability, propagation potential, and differentiation ability. Stem cells are cells that have the ability to reproduce (self-renewal), do not yet have a specific shape and functions (undifferentiated), but have the ability todifferentiate into other cells. One type of stem cell is mesenchymal stem cell (MSC) which can differentiate in vitro into other cells including neurons. In addition MSC can secrete various neurotrophic factors that can play a role in angiogenesis and synaptic formation, so that, it is relevant to stroke therapy. This paper describes the research and development of stem cell applications in stroke therapy through several research results. This paper is in the form of a literature review obtained through literature searches. The results showed that MSC is able to differentiate and replace damaged neurons after transplantation based on the results of studies in vitro, in vivo, and several clinical trials. The technique in the differentiation of MSCinto neurons is the addition of certain growth factors to the culture medium in vitro. Meanwhile, in vivo studies have shown that that administration of MSC can replace damaged cells, provide neuroprotective effect, induce axon growth, stimulate angiogenesis, and neurogenesis in stroke animal models using the middle cerebral artery occlusion (MCAO) method. Therefore, MSCs have the potential to treat degenerative diseases, especially stroke. From the results of clinical trials, it can be seen that stem cells are safe to give to stroke patients, there is clinical improvement, and neurological improvement, as well as a reduction in brain lesions. However, there are several challenges for the development and application of MSS for stroke therapy in the future such as concerns about tumorigenesis and high cost.  \u0000Abstrak \u0000Stroke adalah penyakit neurodegeneratif yang dapat menyebabkan kecacatan hingga kematian. Terapi stroke menggunakan sel punca mulai dipikirkan sebagai alternatif dilihat dari aspek ketersediaan, potensi perbanyakan, dan kemampuan diferensiasinya. Sel punca merupakan sel yang memiliki kemampuan memperbanyak diri (self renewal), belum mempunyai bentuk dan fungsi yang spesifik (undifferentiated), namun memiliki kemampuan untuk berdiferensiasi menjadi sel lainnya. Salah satu jenis sel punca adalah sel punca mesenkim (SPM) yang dapat berdiferensiasi secara in vitro menjadi sel lain termasuk neuron. Selain itu, SPM dapat menyekresikan berbagai faktor neurotrofik yang dapat berperan dalam angiogenesis dan pembentukan sinaptik sehingga relevan terhadap terapi terhadap stroke. Tulisan ini menguraikan tentang penelitian dan pengembangan sel punca dalam terapi stroke melalui beberapa hasil penelitian. Tulisan ini berupa review literatur yang didapatkan melalui penelusuran pustaka. Hasilnya menunjukkan bahwa SPM mampu","PeriodicalId":18323,"journal":{"name":"Media Penelitian dan Pengembangan Kesehatan","volume":"7 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83976486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic Review : Determinan Faktor yang Memengaruhi Kepatuhan Pengobatan Pasien Diabetes Tipe 2 di Indonesia 系统综述:影响2型糖尿病患者治疗坚持的因素因素
IF 0.1 Pub Date : 2021-12-31 DOI: 10.22435/mpk.v31i4.4855
Much Ilham Novalisa Aji Wibowo, Nanang Munif Yasin, Susi Ari Kristina, Yayi Suryo Prabandari
Adherence to pharmacological therapy is the main key in the treatment of diabetes but has not received full attention by clinicians. Several systematic reviews of medication adherence factors have been carried out in several regions of the country. However, it does not feature studies from Indonesia. This study aims to review the factors that can influence diabetes medication adherence in Indonesia. Systematic literature reviews were carried out through searching the database of National (Garuda and Sinta) and International (PubMed and Science Direct) journals. Research that met the inclusion criteria and published in January 2011 - December 2020. The quality of the study was assessed using SQAT guidelines. The research reporting method uses PRISMA guidelines. Adherence factors are classified based on the domain of compliance factors according to World Health Organizatin (WHO). A total of 370 scientific research from the Garuda database (n = 36); Science direct (n = 108); PubMed (n = 18); Sinta (n = 208). Three hundred forty-one (341) studies were excluded, 29 full-text screening, 16 research articles met the inclusion criteria for analysis. Factors that affect adherence to diabetes medication are social and economic (income, education level, and occupation); labor and health system factors (health workers); patient therapy factors (number of diabetes medicines, frequency of taking medication, and drug product); factors patient disease (blood sugar levels, duration of illness); patient factors (gender, emotional factors, social support, level of knowledge and treatment satisfaction); anddisease management factors (counseling and pharmacy education). Factors that affect adherence to diabetes medication in Indonesia are very diverse and multi-factorial. These factors can serve as targets for relevant interventions. Clinicians need to consider adjusting the frequency of taking medication and providing social support to diabetes patients.  Abstrak Kepatuhan terhadap terapi farmakologi merupakan kunci utama pengobatan penyakit diabetes, tetapi belum mendapat perhatian penuh oleh para klinisi. Beberapa systematic review faktor kepatuhan telah dilakukan di beberapa kawasan negara. Namun, tidak menampilkan studi dari Indonesia. Penelitian ini bertujuan untuk meninjau secara sistematis faktor-faktor yang dapat memengaruhi kepatuhan minum obat diabetes melitus (DM) di Indonesia. Systematic literature review dilakukan melalui pencarian pada database jurnal Nasional (Garuda dan Sinta) dan Internasional (PubMed dan Science Direct). Penelitian yang sesuai dengan kriteria inklusi dan dipublikasikan pada Januari 2011 – Desember 2020. Kualitas penelitian dinilai menggunakan panduan SQAT. Metode pelaporan penelitian menggunakan pedoman PRISMA. Faktor kepatuhan diklasifikasikan berdasarkan domain faktor kepatuhan menurut World Health Organization (WHO). Sebanyak 370 artikel ilmiah penelitian dari database Garuda (n=36); Science Direct (n= 108); PubMed (n= 18); Si
坚持药物治疗是糖尿病治疗的关键,但尚未得到临床医生的充分重视。已在该国若干地区对药物依从性因素进行了若干系统审查。然而,它并没有包括来自印度尼西亚的研究。本研究旨在回顾影响印度尼西亚糖尿病药物依从性的因素。通过检索国家(Garuda和Sinta)和国际(PubMed和Science Direct)期刊数据库进行系统文献综述。2011年1月至2020年12月期间发表的符合纳入标准的研究。使用SQAT指南评估研究的质量。研究报告方法采用PRISMA指南。依从性因素根据世界卫生组织(世卫组织)的依从性因素领域进行分类。来自鹰航数据库的370项科学研究(n = 36);Science direct (n = 108);PubMed (n = 18);Sinta (n = 208)。341项研究被排除,29篇全文筛选,16篇研究文章符合纳入标准。影响糖尿病药物依从性的因素是社会和经济因素(收入、教育水平和职业);劳动力和卫生系统因素(卫生工作者);患者治疗因素(糖尿病药物数量、用药频次、药品);患者疾病因素(血糖水平、病程);患者因素(性别、情绪因素、社会支持、知识水平、治疗满意度);疾病管理因素(咨询和药学教育)。在印度尼西亚,影响糖尿病药物依从性的因素是非常多样化和多因素的。这些因素可作为相关干预措施的目标。临床医生需要考虑调整糖尿病患者的服药频率和提供社会支持。【摘要】Kepatuhan terhadap terapapologologi merupakan kunci utama pengobatan penyaki糖尿病,tepatuhan belum penapapat perhatih糖尿病。Beberapa系统评价因子kepatuhan telah dilakukan di Beberapa kawasan negara。Namun, tidak menampilkan studi dari Indonesia。Penelitian ini bertujuan untuk meninjau secara系统因子因子yang dapat menengaruhi kepatuhan轻度糖尿病(DM)印度尼西亚。系统文献综述dilakukan melalui pencarian数据库期刊Nasional (Garuda dan Sinta) and international (PubMed and Science Direct)。2011年1月- 2020年12月。昆明市,昆明市,昆明市,昆明市。孟古纳坎,孟古纳坎,孟古纳坎。世界卫生组织(世卫组织)。Sebanyak 370 artikel ilmiah penelitian dari数据库Garuda (n=36);Science Direct (n= 108);PubMed (n= 18);Sinta (n= 208)。[341] article penelitian diekskllusi, 29 article skrining全文,[16]article penelitian memmemuhi kriteria inklusi untuk dianalysis。Faktor yang memengaruhi kepatuhan minobat diabetes, adala Faktor social dan economi (penghasilan, tingkat pendidikan, dan pekerjaan), Faktor tenaga dan系统kesehatan (tenaga kesehatan), Faktor terapi pasien (jumlah obat diabetes, frekuensi minobat, dan produk obat), Faktor penyakit pasien (kadar gula darah, durasi penyakit), Faktor pasien (jenis kelamin, fakar emoemote, dukungan social, tingkat pengetahuan, dan kepuasan pengobatan),Dan faktor pengelolaan penyakit(咨询Dan edukasi farmasi)。Faktor yang memengaruhi kepatuhan最低工资DM di印度尼西亚sangat beragam,多因素。因素terterf的变化与目标干预阳相关。Para klinisi perlu member pertimbangkan penyesuaian frekuensi minimum obat an penberian dukungan social kemada pasien DM。
{"title":"Systematic Review : Determinan Faktor yang Memengaruhi Kepatuhan Pengobatan Pasien Diabetes Tipe 2 di Indonesia","authors":"Much Ilham Novalisa Aji Wibowo, Nanang Munif Yasin, Susi Ari Kristina, Yayi Suryo Prabandari","doi":"10.22435/mpk.v31i4.4855","DOIUrl":"https://doi.org/10.22435/mpk.v31i4.4855","url":null,"abstract":"Adherence to pharmacological therapy is the main key in the treatment of diabetes but has not received full attention by clinicians. Several systematic reviews of medication adherence factors have been carried out in several regions of the country. However, it does not feature studies from Indonesia. This study aims to review the factors that can influence diabetes medication adherence in Indonesia. Systematic literature reviews were carried out through searching the database of National (Garuda and Sinta) and International (PubMed and Science Direct) journals. Research that met the inclusion criteria and published in January 2011 - December 2020. The quality of the study was assessed using SQAT guidelines. The research reporting method uses PRISMA guidelines. Adherence factors are classified based on the domain of compliance factors according to World Health Organizatin (WHO). A total of 370 scientific research from the Garuda database (n = 36); Science direct (n = 108); PubMed (n = 18); Sinta (n = 208). Three hundred forty-one (341) studies were excluded, 29 full-text screening, 16 research articles met the inclusion criteria for analysis. Factors that affect adherence to diabetes medication are social and economic (income, education level, and occupation); labor and health system factors (health workers); patient therapy factors (number of diabetes medicines, frequency of taking medication, and drug product); factors patient disease (blood sugar levels, duration of illness); patient factors (gender, emotional factors, social support, level of knowledge and treatment satisfaction); anddisease management factors (counseling and pharmacy education). Factors that affect adherence to diabetes medication in Indonesia are very diverse and multi-factorial. These factors can serve as targets for relevant interventions. Clinicians need to consider adjusting the frequency of taking medication and providing social support to diabetes patients.  \u0000Abstrak \u0000Kepatuhan terhadap terapi farmakologi merupakan kunci utama pengobatan penyakit diabetes, tetapi belum mendapat perhatian penuh oleh para klinisi. Beberapa systematic review faktor kepatuhan telah dilakukan di beberapa kawasan negara. Namun, tidak menampilkan studi dari Indonesia. Penelitian ini bertujuan untuk meninjau secara sistematis faktor-faktor yang dapat memengaruhi kepatuhan minum obat diabetes melitus (DM) di Indonesia. Systematic literature review dilakukan melalui pencarian pada database jurnal Nasional (Garuda dan Sinta) dan Internasional (PubMed dan Science Direct). Penelitian yang sesuai dengan kriteria inklusi dan dipublikasikan pada Januari 2011 – Desember 2020. Kualitas penelitian dinilai menggunakan panduan SQAT. Metode pelaporan penelitian menggunakan pedoman PRISMA. Faktor kepatuhan diklasifikasikan berdasarkan domain faktor kepatuhan menurut World Health Organization (WHO). Sebanyak 370 artikel ilmiah penelitian dari database Garuda (n=36); Science Direct (n= 108); PubMed (n= 18); Si","PeriodicalId":18323,"journal":{"name":"Media Penelitian dan Pengembangan Kesehatan","volume":"40 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77056315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hubungan Beban Kerja, Work-Family Conflict, dan Stres Kerja pada Pekerja di Wilayah Pulau Jawa Saat Pandemi COVID-19 di Tahun 2020
IF 0.1 Pub Date : 2021-12-31 DOI: 10.22435/mpk.v31i4.4377
Arifah Alfi Maziyya, Nadzira Risalati Qoryatul Islam, Hoirun Nisa
The COVID-19 pandemic has an impact on all levels of society, including workers. Around 80% of workers experience symptoms of stress during the COVID-19 pandemic. Workload and work-family conflict (multiple role conflicts) can trigger work stress. This study aimed to determine the relationship between workload and work-family conflict with work stress on workers on Java during the COVID-19 pandemic in 2020. This study used a cross-sectional study design. There were 436 respondents, obtained through the accidental sampling method. Data collection was carried out online using google form in October 2020. Multivariate analysis was carried out using multiple logistic regression tests. The results showed that 47.2% of workers experienced high levels of stress. The results of multivariate analysis that have been controlled with variables of age, marital status, type of work, length of work, and average income indicate that the workload (AOR = 2.55, 95% CI = 1.71-3.80) and work -family conflict (AOR=7.33, 95% CI = 4.72-11.37) was significantly associated with the incidence of work stress during the COVID-19 pandemic. The conclusion in this study is that workload and work-family conflict are related to the stress level of workers. The high level of work-family conflict is the most dominant factor related to the stress level of workers during the COVID-19 pandemic. This study recommends the importance of stress management for workers during a pandemic to prevent work stress. Abstrak Pandemi COVID-19 berdampak pada seluruh lapisan masyarakat, termasuk pekerja. Sekitar 80% pekerja mengalami gejala stres selama masa pandemi COVID-19. Beban kerja dan work-family conflict (konflik peran ganda) dapat memicu terjadinya stres kerja. Penelitian ini bertujuan untuk mengetahui hubungan antara beban kerja dan work-family conflict dengan stres kerja pada pekerja di pulau Jawa saat pandemi COVID-19 tahun 2020. Penelitian ini menggunakan desain studi cross-sectional. Jumlah responden pada penelitian ini sebanyak 436 responden yang dipilih menggunakan metode accidental sampling. Pengumpulan data dilakukan secara online menggunakan google form pada bulan Oktober 2020. Analisis multivariat dilakukan dengan uji regresi logistik berganda. Hasil penelitian menunjukkan sebanyak 47,2% pekerja mengalami tingkat stres tinggi. Hasil analisis multivariat yang telah dikontrol dengan variabel usia, status pernikahan, jenis pekerjaan, lama bekerja, dan rata-rata pendapatan menunjukkan bahwa beban kerja (AOR=2,55, CI 95% = 1,71-3,80) dan work-family conflict (AOR=7,33, CI 95% = 4,72-11,37) berhubungan secara signifikan dengan kejadian stres kerja pada masa pandemi COVID-19. Simpulan dalam penelitian ini adalah beban kerja dan work-familyconflict berhubungan dengan tingkat stress pekerja. Work-family conflict yang tinggi menjadi faktor paling dominan berhubungan dengan tingkat stres pekerja pada masa pandemi COVID-19. Penelitian ini merekomendasikan pentingnya manajemen stres pada pek
2019冠状病毒病大流行对包括工人在内的社会各阶层都产生了影响。在COVID-19大流行期间,约80%的工人会出现压力症状。工作量和工作-家庭冲突(多重角色冲突)会引发工作压力。本研究旨在确定2020年COVID-19大流行期间爪哇工人的工作量和工作-家庭冲突与工作压力之间的关系。本研究采用横断面研究设计。调查对象436人,采用随机抽样法。数据收集于2020年10月使用谷歌表格在线进行。采用多元逻辑回归检验进行多因素分析。结果显示,47.2%的员工承受着高水平的压力。经年龄、婚姻状况、工作类型、工作时长、平均收入等变量控制的多因素分析结果显示,工作量(AOR= 2.55, 95% CI = 1.71 ~ 3.80)和工作家庭冲突(AOR=7.33, 95% CI = 4.72 ~ 11.37)与新冠肺炎大流行期间工作压力发生率显著相关。本研究的结论是工作量和工作-家庭冲突与员工的压力水平有关。高水平的工作-家庭冲突是与COVID-19大流行期间工人压力水平相关的最主要因素。这项研究建议在大流行期间对工人进行压力管理,以防止工作压力。【摘要】2019冠状病毒病(COVID-19)流行病学分析。Sekitar 80% pekerja mengalami gejala强调selama masa大流行COVID-19。Beban kerja和工作-家庭冲突(konflik peran ganda)。Penelitian ini bertujuan untuk mengetahui hubungan antara beban kerja dan工作-家庭冲突邓根强调,在2020年2019冠状病毒病(COVID-19)大流行期间,kerja papja pekerja di pulau。Penelitian ini menggunakan设计研究横截面。抽样方法:抽样方法:抽样方法:抽样方法:抽样方法:抽样方法:抽样方法。彭普兰数据dilakukan secara在线蒙古纳坎谷歌形式帕达布兰2020年10月。多变量logistic回归分析。Hasil penelitian menunjukkan sebanyak 47,2% pekerja mengalami tingkat强调tinggi。多变量的Hasil分析显示,多变量的影响因素包括:发病、发病、发病、发病、发病、发病和发病(AOR=2,55, CI 95% = 1,71-3,80)和工作-家庭冲突(AOR=7,33, CI 95% = 4,72-11,37)和发病、发病、发病、发病、发病、发病、发病、发病、发病、发病、发病、发病、发病、发病、发病等。Simpulan dalam penelitian ini adalah beban kerja dan工作-家庭冲突berhubungan dengan tingkat stress pekerja。工作-家庭冲突杨廷吉门加迪是导致新冠肺炎大流行的主要原因。Penelitian说:“我的意思是说,我的意思是说,我的意思是说,我的意思是说,我的意思是说,我的意思是说,我的意思是说,我的意思是说,我的意思是说,我的意思是我的意思。”
{"title":"Hubungan Beban Kerja, Work-Family Conflict, dan Stres Kerja pada Pekerja di Wilayah Pulau Jawa Saat Pandemi COVID-19 di Tahun 2020","authors":"Arifah Alfi Maziyya, Nadzira Risalati Qoryatul Islam, Hoirun Nisa","doi":"10.22435/mpk.v31i4.4377","DOIUrl":"https://doi.org/10.22435/mpk.v31i4.4377","url":null,"abstract":"The COVID-19 pandemic has an impact on all levels of society, including workers. Around 80% of workers experience symptoms of stress during the COVID-19 pandemic. Workload and work-family conflict (multiple role conflicts) can trigger work stress. This study aimed to determine the relationship between workload and work-family conflict with work stress on workers on Java during the COVID-19 pandemic in 2020. This study used a cross-sectional study design. There were 436 respondents, obtained through the accidental sampling method. Data collection was carried out online using google form in October 2020. Multivariate analysis was carried out using multiple logistic regression tests. The results showed that 47.2% of workers experienced high levels of stress. The results of multivariate analysis that have been controlled with variables of age, marital status, type of work, length of work, and average income indicate that the workload (AOR = 2.55, 95% CI = 1.71-3.80) and work -family conflict (AOR=7.33, 95% CI = 4.72-11.37) was significantly associated with the incidence of work stress during the COVID-19 pandemic. The conclusion in this study is that workload and work-family conflict are related to the stress level of workers. The high level of work-family conflict is the most dominant factor related to the stress level of workers during the COVID-19 pandemic. This study recommends the importance of stress management for workers during a pandemic to prevent work stress. \u0000Abstrak \u0000Pandemi COVID-19 berdampak pada seluruh lapisan masyarakat, termasuk pekerja. Sekitar 80% pekerja mengalami gejala stres selama masa pandemi COVID-19. Beban kerja dan work-family conflict (konflik peran ganda) dapat memicu terjadinya stres kerja. Penelitian ini bertujuan untuk mengetahui hubungan antara beban kerja dan work-family conflict dengan stres kerja pada pekerja di pulau Jawa saat pandemi COVID-19 tahun 2020. Penelitian ini menggunakan desain studi cross-sectional. Jumlah responden pada penelitian ini sebanyak 436 responden yang dipilih menggunakan metode accidental sampling. Pengumpulan data dilakukan secara online menggunakan google form pada bulan Oktober 2020. Analisis multivariat dilakukan dengan uji regresi logistik berganda. Hasil penelitian menunjukkan sebanyak 47,2% pekerja mengalami tingkat stres tinggi. Hasil analisis multivariat yang telah dikontrol dengan variabel usia, status pernikahan, jenis pekerjaan, lama bekerja, dan rata-rata pendapatan menunjukkan bahwa beban kerja (AOR=2,55, CI 95% = 1,71-3,80) dan work-family conflict (AOR=7,33, CI 95% = 4,72-11,37) berhubungan secara signifikan dengan kejadian stres kerja pada masa pandemi COVID-19. Simpulan dalam penelitian ini adalah beban kerja dan work-familyconflict berhubungan dengan tingkat stress pekerja. Work-family conflict yang tinggi menjadi faktor paling dominan berhubungan dengan tingkat stres pekerja pada masa pandemi COVID-19. Penelitian ini merekomendasikan pentingnya manajemen stres pada pek","PeriodicalId":18323,"journal":{"name":"Media Penelitian dan Pengembangan Kesehatan","volume":"52 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84581909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Studi Kasus di Indonesia: Kepatuhan Pengisian Clinical Pathway Stroke Iskemik dan STEMI di Beberapa Rumah Sakit Tahun 2019
IF 0.1 Pub Date : 2021-12-30 DOI: 10.22435/mpk.v31i4.4955
Telly Purnamasari Agus, Made Ayu Lely Suratri, Tetra Fajarwati
A clinical pathway (CP) is a flow of clinical service provided to patients from entering to leaving the hospital. Clinical pathways are needed as an effort to improve the quality and control the cost of services in hospitals. Some hospitals that have developed CP have not fully implemented it to patients. On the other hand, hospitals that have implemented CP, still encounter general problems, such is low compliance with CP. The purpose of this study was to obtain an overview of compliance with filling out the clinical pathway (CP) form for ischemic stroke and ST-Elevation Myocardial Infarction (STEMI) cases in several hospitals in Indonesia. The research was conducted in public and private hospitals class A and B which have implemented CP for ischemic stroke and STEMI in 2019. Data collection was carried out in 20 hospitals spread across 11 provinces in 5 regions. The research is a case study using a mix method design. Quantitative data collection was carried out by observing/checking the CP form document for ischemic stroke and STEMI, to determine compliance in filling out of ischemic stroke and STEMI CP forms. Compliance is measured in five care services, namely medical care, nursing, support, pharmacy and nutrition. It is stated as compliant if the percentage of filling in the CP is ≥80%. The total number of 1094 CPs consisted of 681 ischemic ischemic stroke CPs and 413 STEMI CPs. The results showed that: 1). Compliance with implementing ischemic stroke CP is very low, only 32 out of 681 (5%) CP filled ≥80% in five care services, 2). Compliance with implementing STEMI CP is also very low, only 81 out of 413 (20%) CP filled ≥80% in five care services.The conclusion of the study showed that compliance with filling CP ischemic stroke and CP STEMI was very low, as measured by 5 types of care services (medical care, nursing care, supporting care, pharmaceutical care, and nutritional care).  Abstrak Clinical pathway (CP) merupakan suatu alur pelayanan klinik yang diberikan pada pasien sejak masuk hingga keluar rumah sakit. Clinical pathway diperlukan dalam upaya meningkatkan mutu dan pengendalian biaya pelayanan di rumah sakit. Beberapa rumah sakit yang telah mengembangkan CP belum seluruhnya mengimplementasikan pada pasien. Di sisi lain rumah sakit yang telah mengimplementasikan CP, masih menemui kendala umum yaitu rendahnya kepatuhan terhadap CP. Tujuan penelitian untuk memperoleh gambaran kepatuhan pengisian formulir clinical pathway (CP) kasus stroke iskemik dan ST-Elevation Myocardial Infarction (STEMI) di beberapa rumah sakit di Indonesia. Penelitian dilakukan di rumah sakit pemerintah dan swasta kelas A dan B yang telah mengimplementasikan CP kasus stroke iskemik dan STEMI pada tahun 2019. Pengumpulan data dilakukan di 20 rumah sakit yang tersebar di 11 provinsi dalam 5 regional. Penelitian berupa studi kasus menggunakan desain mix method. Pengumpulan data kuantitatif dengan cara melakukan observasi/ cek dokumen formulir CP stroke iskemik d
临床路径(CP)是向患者提供从进入医院到离开医院的临床服务的流程。临床路径是提高医院服务质量和控制服务成本的一项努力。一些开发了CP的医院并没有对患者完全实施CP。另一方面,实施CP的医院仍然存在普遍的问题,如CP的依从性较低。本研究的目的是了解印度尼西亚几家医院缺血性卒中和st段抬高型心肌梗死(STEMI)病例填写临床路径(CP)表的依从性概况。本研究在2019年实施缺血性脑卒中CP和STEMI的公立和私立A、B类医院进行。在5个地区11个省的20家医院进行了数据收集。本研究是采用混合方法设计的案例研究。通过观察/检查缺血性卒中和STEMI CP表格文件进行定量数据收集,以确定缺血性卒中和STEMI CP表格填写的依从性。遵守情况以五项护理服务衡量,即医疗、护理、支助、药房和营养。CP中填充率≥80%为合格。1094例CPs中,缺血性脑卒中CPs 681例,STEMI CPs 413例。结果表明:1)缺血性卒中患者执行CP的依从性很低,681例(5%)CP填写≥80%;2)STEMI患者执行CP的依从性也很低,413例(20%)CP填写≥80%。研究结论表明,通过5种护理服务(医疗、护理、支持、药学和营养护理)衡量,填充CP缺血性卒中和CP STEMI的依从性很低。【摘要】临床途径(CP)是治疗糖尿病的一种有效途径,是治疗糖尿病的一种有效途径。临床途径:临床途径、临床途径、临床途径、临床途径、临床途径。Beberapa rumah sakit yang telah mengembangkan CP belum seluruhnya mengimplementaskan pada pasen。图juan penelitian untuk memperoleh gambaran kepatuhan pengisian处方临床通路(CP) kasus卒中iskemik dan st段升高型心肌梗死(STEMI) Di beberapa rumah sakit Di印度尼西亚。2019年12月29日,中国人民解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军解放军。彭普兰的数据为:dilakukan di 20, rumah sakit yang tersebar di 11个省,dalam 5个地区。Penelitian berupa研究kasus menggunakan设计混合方法。彭普兰数据定量分析:邓根根、卡拉库拉坎观察/ cekma配方CP卒中风险与STEMI, untuk mengetahui kepatuhan dalam mengisi配方CP卒中风险与STEMI。Kepatuhan diukur pada lima asuhan pelayanan yitu asuhan mediis, keperawatan, penunjang, farmasi dan nutrisi..Dikatakan patuh jika代表彭氏蕨≥80%。Jumlah共1094 CP terdiri dari 681 CP卒中iskemik dan 413 CP STEMI。Diketahui dari hasil penelitian bahwa: 1). Kepatuhan melaksanakan CP stroke iskemik sangat rendah, hanya 32 dari 681 (5%) . CP terisi≥80% pada lima asuhan pelayanan 2). Kepatuhan melaksanakan CP STEMI juga sangat rendah, yitu 81 dari 413 (20%) . CP terisi≥80% pada lima asuhan pelayanan。kespulpan penelitian menunjukkan bahwa kepatuhan pengisian CP stroke iskemik dan CP STEMI sangat rendah, yang diukur dari 5 jenis asuhan pelayanan (asuhan mediis, asuhan keperawatan, asuhan penunjang, asuhan farmasi, dan asuhan nutrisi)。
{"title":"Studi Kasus di Indonesia: Kepatuhan Pengisian Clinical Pathway Stroke Iskemik dan STEMI di Beberapa Rumah Sakit Tahun 2019","authors":"Telly Purnamasari Agus, Made Ayu Lely Suratri, Tetra Fajarwati","doi":"10.22435/mpk.v31i4.4955","DOIUrl":"https://doi.org/10.22435/mpk.v31i4.4955","url":null,"abstract":"A clinical pathway (CP) is a flow of clinical service provided to patients from entering to leaving the hospital. Clinical pathways are needed as an effort to improve the quality and control the cost of services in hospitals. Some hospitals that have developed CP have not fully implemented it to patients. On the other hand, hospitals that have implemented CP, still encounter general problems, such is low compliance with CP. The purpose of this study was to obtain an overview of compliance with filling out the clinical pathway (CP) form for ischemic stroke and ST-Elevation Myocardial Infarction (STEMI) cases in several hospitals in Indonesia. The research was conducted in public and private hospitals class A and B which have implemented CP for ischemic stroke and STEMI in 2019. Data collection was carried out in 20 hospitals spread across 11 provinces in 5 regions. The research is a case study using a mix method design. Quantitative data collection was carried out by observing/checking the CP form document for ischemic stroke and STEMI, to determine compliance in filling out of ischemic stroke and STEMI CP forms. Compliance is measured in five care services, namely medical care, nursing, support, pharmacy and nutrition. It is stated as compliant if the percentage of filling in the CP is ≥80%. The total number of 1094 CPs consisted of 681 ischemic ischemic stroke CPs and 413 STEMI CPs. The results showed that: 1). Compliance with implementing ischemic stroke CP is very low, only 32 out of 681 (5%) CP filled ≥80% in five care services, 2). Compliance with implementing STEMI CP is also very low, only 81 out of 413 (20%) CP filled ≥80% in five care services.The conclusion of the study showed that compliance with filling CP ischemic stroke and CP STEMI was very low, as measured by 5 types of care services (medical care, nursing care, supporting care, pharmaceutical care, and nutritional care).  \u0000Abstrak \u0000Clinical pathway (CP) merupakan suatu alur pelayanan klinik yang diberikan pada pasien sejak masuk hingga keluar rumah sakit. Clinical pathway diperlukan dalam upaya meningkatkan mutu dan pengendalian biaya pelayanan di rumah sakit. Beberapa rumah sakit yang telah mengembangkan CP belum seluruhnya mengimplementasikan pada pasien. Di sisi lain rumah sakit yang telah mengimplementasikan CP, masih menemui kendala umum yaitu rendahnya kepatuhan terhadap CP. Tujuan penelitian untuk memperoleh gambaran kepatuhan pengisian formulir clinical pathway (CP) kasus stroke iskemik dan ST-Elevation Myocardial Infarction (STEMI) di beberapa rumah sakit di Indonesia. Penelitian dilakukan di rumah sakit pemerintah dan swasta kelas A dan B yang telah mengimplementasikan CP kasus stroke iskemik dan STEMI pada tahun 2019. Pengumpulan data dilakukan di 20 rumah sakit yang tersebar di 11 provinsi dalam 5 regional. Penelitian berupa studi kasus menggunakan desain mix method. Pengumpulan data kuantitatif dengan cara melakukan observasi/ cek dokumen formulir CP stroke iskemik d","PeriodicalId":18323,"journal":{"name":"Media Penelitian dan Pengembangan Kesehatan","volume":"73 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77298737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Media Penelitian dan Pengembangan Kesehatan
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1